[HTML][HTML] Evaluation of polymer nanoformulations in hepatoma therapy by established rodent models
Q Wang, P Zhang, Z Li, X Feng, C Lv, H Zhang… - Theranostics, 2019 - ncbi.nlm.nih.gov
Hepatoma is one of the most severe malignancies usually with poor prognosis, and many
patients are insensitive to the existing therapeutic agents, including the drugs for …
patients are insensitive to the existing therapeutic agents, including the drugs for …
[HTML][HTML] Polymeric nanomedicines for the treatment of hepatic diseases
The liver is an important organ in the human body and performs many functions, such as
digestion, detoxification, metabolism, immune responses, and vitamin and mineral storage …
digestion, detoxification, metabolism, immune responses, and vitamin and mineral storage …
Novel polymeric nanoparticles containing tanshinone IIA for the treatment of hepatoma
Q Li, Y Wang, N Feng, Z Fan, J Sun… - Journal of drug …, 2008 - Taylor & Francis
Novel polylactic acid nanoparticles containing tanshinone IIA (TS-PLA-NPs) were
synthesized by a single oil-in-water emulsion/solvent evaporation method. In this study, the …
synthesized by a single oil-in-water emulsion/solvent evaporation method. In this study, the …
New molecular targets for functionalized nanosized drug delivery systems in personalized therapy for hepatocellular carcinoma
C Turato, A Balasso, V Carloni, C Tiribelli… - Journal of Controlled …, 2017 - Elsevier
Hepatocellular carcinoma, the most frequent solid tumor of the liver, has a very poor
prognosis, being the second most common cause of death from cancer worldwide. The …
prognosis, being the second most common cause of death from cancer worldwide. The …
Heparosan as a potential alternative to hyaluronic acid for the design of biopolymer-based nanovectors for anticancer therapy
M Rippe, TF Stefanello, V Kaplum, EA Britta… - Biomaterials …, 2019 - pubs.rsc.org
Glycosaminoglycans (GAGs) are important components of the extracellular matrix that have
attracted great interest for drug delivery and pharmaceutical applications due to their diverse …
attracted great interest for drug delivery and pharmaceutical applications due to their diverse …
Generation of matched patient-derived xenograft in vitro-in vivo models using 3D macroporous hydrogels for the study of liver cancer
Hepatocellular carcinoma (HCC) is the third leading cause of cancer death worldwide, often
manifesting at the advanced stage when cure is no longer possible. The discrepancy …
manifesting at the advanced stage when cure is no longer possible. The discrepancy …
Delivery of triptolide with reduction-sensitive polymer nanoparticles for liver cancer therapy on patient-derived xenografts models
Hepatocellular carcinoma (HCC) has become the fourth predominant cause of cancer-
related deaths worldwide, and HCC is still one of the worst prognoses for survival as it is …
related deaths worldwide, and HCC is still one of the worst prognoses for survival as it is …
Facile Fabrication of Nanoparticles with Dual-Targeting Ligands for Precise Hepatocellular Carcinoma Therapy In Vitro and In Vivo
Y Xiang, W Huang, C Huang, J Long… - Molecular …, 2020 - ACS Publications
Efficient hepatocellular carcinoma (HCC) therapy remains a significant challenge due to the
unsatisfactory targeting efficiency of nanoparticles (NPs) with either a passive targeting or a …
unsatisfactory targeting efficiency of nanoparticles (NPs) with either a passive targeting or a …
[HTML][HTML] Liver cancer: current and future trends using biomaterials
Hepatocellular carcinoma (HCC) is the fifth most common type of cancer diagnosed and the
second leading cause of death worldwide. Despite advancement in current treatments for …
second leading cause of death worldwide. Despite advancement in current treatments for …
Nanomedicines: a theranostic approach for hepatocellular carcinoma
The liver is an imperative organ of tremendous importance concerned with maintenance of
metabolic functions and detoxification of exogenous and endogenous challenges like …
metabolic functions and detoxification of exogenous and endogenous challenges like …